Comparison of the Occlutech? Figulla? Septal Occluder and Amplatzer? Septal Occluder for Atrial Septal Defect Device Closure

详细信息    查看全文

• 作者：Supaporn Roymanee ; Worakan Promphan ; Nakharin Tonklang…
• 关键词：ASD device closure ; ASD percutaneous closure ; Occlutech septal occluder ; Amplatzer septal occluder
• 刊名：Pediatric Cardiology
• 出版年：2015
• 出版时间：June 2015
• 年：2015
• 卷：36
• 期：5
• 页码：935-941
• 全文大小：1,115 KB
• 参考文献：1.Abaci A, Unlu S, Alsancak Y, Kaya U, Sezenoz B (2013) Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies. Catheter Cardiovasc Interv 82:1123-138. doi:10.-002/?ccd.-4875 View Article PubMed
  2.Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS (2004) Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 63:496-02View Article PubMed
  3.Ammar RI, Hegazy RA (2013) Transcatheter closure of secundum ASD using Occlutech Figulla-N device in symptomatic children younger than 2?years of age. J Invasive Cardiol 25:76-9PubMed
  4.Aytemir K, Oto A, Ozkutlu S, Kaya EB, Canpolat U, Yorgun H, Sahiner L, Kabak?i G (2012) Early-mid term follow-up results of percutaneous closure of the interatrial septal defects with occlutech figulla devices: a single center experience. J Interv Cardiol 25:375-81View Article PubMed
  5.Cansel M, Pekdemir H, Ya?mur J, Tasolar H, Ermis N, Kurtoglu E, Ac?kgoz N, Atas H, Ozdemir R (2011) Early single clinical experience with the new Figulla ASD occluder for transcatheter closure of atrial septal defect in adults. Arch Cardiovasc Dis 104:155-60View Article PubMed
  6.DiBardino DJ, McElhinney DB, Kaza AK, Mayer JE Jr (2009) Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database. J Thorac Cardiovasc Surg 137:1334-341. doi:10.-016/?j.?jtcvs.-009.-2.-32 View Article PubMed Central PubMed
  7.Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K (2002) Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol 39:1836-844View Article PubMed
  8.Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Sriyoschati S, Ponvilawan S, Subtaweesin T, Kangkagate C (2002) Comparison of atrial septal defect closure using amplatzer septal occluder with surgery. Pediatr Cardiol 23:36-0View Article PubMed
  9.FDA executive summary memorandum (2012) Transcatheter ASD occluders: clinical update and review of events, [online]. http://?www.?fda.?gov/?downloads/?AdvisoryCommitte?es/?CommitteesMeetin?gMaterials/?MedicalDevices/?MedicalDevicesAd?visoryCommittee/?CirculatorySyste?mDevicesPanel/?UCM304924.?pdf . Accessed 17 July 2014
  10.Fu YC, Cao QL, Hijazi ZM (2007) Device closure of large atrial septal defects: technical considerations. J Cardiovasc Med 8:30-3View Article
  11.Halabi A, Hijazi ZM (2008) A new device to close secundum atrial septal defects: first clinical use to close multiple defects in a child. Catheter Cardiovasc Interv 71:853-56View Article PubMed
  12.Harper RW, Mottram PM, McGaw DJ (2002) Closure of secundum atrial septal defects with the Amplatzer septal occluder device: techniques and problems. Catheter Cardiovasc Interv 57:508-24View Article PubMed
  13.Ilkay E, Ka?maz F, ?zeke ?, Turan RS, Firat S, Pampal K, Ozer E, Bilgin S (2010) The efficiency and safety of percutaneous closure of secundum atrial septal defects with the Occlutech Figulla device: initial clinical experience. Turk Kardiyol Dern Ars 38:189-93PubMed
  14.King TD, Mills NL (1974) Nonoperative closure of atrial septal defects. Surgery 75:383-88PubMed
  15.Krizanic F, Sievert H, Pfeiffer D, Konorza T, Ferrari M, Hijazi Z, Jung C, Lauten A, Figulla HR (2010) The Occlutech Figulla PFO and ASD occluder: a new nitinol wire mesh device for closure of atrial septal defects. J Invasive Cardiol 22:182-87PubMed
  16.Masura J, Gavora P, Podnar T (2005) Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders. J Am Coll Cardiol 45:505-07View Article PubMed
  17.Pac A, Polat TB, Cetin I, Oflaz MB, Balli S (2009) Figulla ASD occluder versus Amplatzer Septal Occluder: a comparative study on validation of a novel device for percutaneous closure of atrial septal defects. J Interv Cardiol 22:489-95View Article PubMed
  18.Quek SC, Wu WX, Chan KY, Ho TF, Yip WC (2010) Transcatheter closure of atrial septal defects: is balloon sizing still necessary? Ann Acad Med Singapore 39:390-93PubMed
  19.Suchon E, Pieculewicz M, Tracz W, Przewlocki T, Sadowski J, Podolec P (2009) Transcatheter closure as an alternative and equivalent method to the surgical treatment of atrial septal defect in adults: comparison of early and late results. Med Sci Monit 15:CR612–CR617PubMed
  20.Tomar M, Khatri S, Radhakrishnan S, Shrivastava S (2011) Intermediate and long-term follow up of percutaneous device closure of fossa ovalis atrial septal defect by the Amplatzer septal occluder
• 作者单位：Supaporn Roymanee (1)
  Worakan Promphan (2)
  Nakharin Tonklang (1)
  Kanjarut Wongwaitaweewong (1)
  
  1. Pediatric Cardiology Unit, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand
  2. Pediatric Cardiac Center, Queen Sirikit National Institute of Child Health, College of Medicine, Rangsit University, Bangkok, Thailand
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Cardiology
  Cardiac Surgery
  Vascular Surgery
  
• 出版者：Springer New York
• ISSN：1432-1971

文摘

The Occlutech? Figulla? septal occluder (OFSO) is a later-generation double-disk device with few reports of its success rates and complications compared with the Amplatzer? septal occluder (ASO), which is the worldwide standard device in percutaneous atrial septal defect (ASD) closure. We recruited and compared the results in 149 patients (76.5?% female) who underwent ASD device closure in our center between January 2003 and June 2012. The patients ranged in age from 2.3 to 77.2?years. There were no statistically significant differences between the two groups regarding patient baseline characteristics and procedure variables. The success rate using either device was excellent (ASO 94.4?% and OFSO 97.4?%; p?=?0.43). Although the diameter of the ASD and the pulmonary arterial pressure in the OFSO group were slightly higher than in the ASO group, the median fluoroscopic time in the OFSO group was significantly shorter (ASO 13.7?min; OFSO 9.0?min; p?<?0.001). The overall median follow-up time was 3.6?years (interquartile range 2.1-.0?years). There were no significant differences between the major and minor complications when comparing the two devices. Both devices were safe and effective for percutaneous ASD closures. The OFSO had the benefit of a shorter fluoroscopic time.